Table 1 Global and regional pooled prevalence rates of MRSA among elderly living in ECCs; results from 119 studies performed in 30 countries
WHO regions*/country | Number of datasets | Number of individuals screened (total) | Number of individuals with MRSA | Pooled prevalence % (95% CI) |
|---|---|---|---|---|
Global | 119 | 164,717 | 16,793 | 14.69 (12.39–17.15) |
Americas | 34 | 86,065 | 7508 | 22.27 (15.56–29.79) |
United States | 31 | 21,457 | 5517 | 23.78 (19.12–28.77) |
Brazil | 2 | 526 | 71 | 13.11 (10.34–16.14) |
Canada | 1 | 64,082 | 1920 | 3.01 (2.87–3.13) |
Western Pacific Region | 18 | 15,419 | 2936 | 16.57 (11.70–22.10) |
China | 12 | 11,337 | 2101 | 18.07 (11.18–26.17) |
Japan | 3 | 354 | 32 | 8.81 (5.99–12.08) |
Singapore | 2 | 3613 | 785 | 21.72 (20.39–23.08) |
Australia | 1 | 115 | 18 | 15.65 (9.55–23.60) |
European region | 65 | 62,893 | 6319 | 10.93 (8.56–13.55) |
Germany | 10 | 10,857 | 432 | 4.67 (2.59–7.29) |
United Kingdom | 8 | 8633 | 2037 | 18.66 (12.07–26.28) |
Belgium | 7 | 13,508 | 1403 | 8.97 (4.94–14.03) |
Italy | 6 | 1710 | 246 | 16.34 (10.23–23.52) |
Spain | 5 | 2700 | 460 | 15.45 (9.50–22.52) |
Sweden | 4 | 1122 | 139 | 4.52 (0.01–33.07) |
Netherlands | 3 | 5841 | 261 | 6.63 (0.01–35.64) |
France | 3 | 1500 | 121 | 13.89 (3.70–29.01) |
Israel | 3 | 545 | 68 | 14.82 (5.28–27.95) |
Switzerland | 3 | 12,128 | 805 | 13.15 (7.08–20.70) |
Finland | 1 | 213 | 2 | 0.94 (0.11–3.35) |
Ireland | 2 | 818 | 82 | 9.46 (7.51–11.61) |
Poland | 2 | 248 | 61 | 22.18 (17.16–27.62) |
Slovenia | 2 | 209 | 22 | 10.50 (6.62–15.09) |
Greece | 1 | 227 | 33 | 14.54 (10.22–19.81) |
Croatia | 1 | 877 | 62 | 7.07 (5.46–8.97) |
Georgia | 1 | 56 | 8 | 14.29 (6.38–26.22) |
Austria | 1 | 500 | 0 | 0.01 (0.00–0.74) |
Luxembourg | 1 | 954 | 69 | 7.23 (5.67–9.06) |
Turkey | 1 | 247 | 8 | 3.24 (1.41–6.28) |
African region | 1 | 152 | 13 | 8.55 (4.63–14.18) |
South Africa | 1 | 152 | 13 | 8.55 (4.63–14.18) |
Eastern Mediterranean | 1 | 188 | 17 | 9.04 (5.36–14.08) |
Saudi Arabia | 1 | 188 | 17 | 9.04 (5.36–14.08) |